4Pearson TA,Mensah GA,Alexander RW,et al.Markers of inflamation and cardiovascular disease [ J ].Circulation,2003,107:499-511.
5Ridker PM.High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention [J]. Am J Cardiol, 2003,92:17-22.
6MaUat Z, Henry P, Fressonnet R, et al .Increased plasma concentrations of interleukinl 8 in acute coronary syndromes [J].Heart,2002,88: 467-469.
7Mallat Z, Corbaz A, Scoazec A, et al. lnterleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability[J]. Circ Res, 2001,89: 41-45.
8Biasucci LM, Liuzzo G, Giubilato S,et al. Delayed neutrophil apoptosis in patients with unstable angina: relation to C-reactive protein and recurrence of instability[J]. Eur Heart J, 2009,30:2220-2225.
9Kawasaki D, Tsujino T, Morimoto S, et al. Plasma interleukin-18 concentration: a novel marker of myocardial isehemia rather than necrosis in humans[J]. Coron Artery Dis, 2005,16:437--441.
10Kai H, Jkeda H, Yasukawa H, et al. Peripheral blood levels of matrix metalloproteinase-2 and -9 are elevated in patients with acute coronary syndromes[J]. Am colt cardioal, 1998,32:368-372.
